The amelioration of liver fibrosis by particular angiogenesis-inhibiting drugs, such as those that target vascular endothelial growth factor receptor-2 (VEGFR-2), demonstrates the importance of angiogenesis in fibrogenesis [1, 12]. Here, KDR is linked to Hepatic fibrosis.